Detalles de la búsqueda
1.
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
Haematologica
; 106(10): 2578-2587, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32855275
2.
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
Biol Blood Marrow Transplant
; 25(12): 2388-2397, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31400502
3.
Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.
Am J Hematol
; 92(5): 429-434, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28181279
4.
Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome.
Biol Blood Marrow Transplant
; 22(11): 1983-1987, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27492792
5.
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 16(15): 1525-1536, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429297
6.
Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation.
Haematologica
; 105(4): e186-e189, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471374
7.
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.
Haematologica
; 100(6): 786-93, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25749825
8.
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica
; 99(5): 916-21, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24389309
9.
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program.
Haematologica
; 98(11): 1718-25, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23753030
10.
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.
Am J Hematol
; 88(12): 1062-7, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23940056
11.
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study.
Transplant Direct
; 9(3): e1451, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36845852
12.
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE).
Bone Marrow Transplant
; 58(6): 659-666, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36894635
13.
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease.
Haematologica
; 97(4): 568-71, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22058217
14.
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma.
Ann Hematol
; 91(1): 73-82, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21559811
15.
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms.
Transplant Cell Ther
; 28(2): 96.e1-96.e11, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34818581
16.
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.
Bone Marrow Transplant
; 57(6): 949-958, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413985
17.
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).
Blood
; 113(18): 4153-62, 2009 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19141862
18.
Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
Haematologica
; 101(6): e245-8, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26992948
19.
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti.
Transplant Cell Ther
; 27(5): 406.e1-406.e11, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965179
20.
Feasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantation.
Biol Blood Marrow Transplant
; 16(11): 1603-7, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20685246